Zhang, Jing
Yang, Yu
Zhou, Shen’ao
He, Xueyan
Cao, Xuan
Wu, Chenlu
Hu, Hong
Qin, Jie
Wei, Gang
Wang, Huayi
Liu, Suling http://orcid.org/0000-0002-0475-0242
Sun, Liming
Funding for this research was provided by:
National Natural Science Foundation of China (31471302, 81530075)
Article History
Received: 20 June 2019
Revised: 9 October 2019
Accepted: 9 October 2019
First Online: 23 October 2019
Compliance with ethical standards
:
: Shanghai Institute of Biochemistry and Cell Biology is in the process of applying for a patent application covering the use of paclitaxel and IAP inhibitors to treat breast cancers that lists JZ and LS as inventors (CN 201811388749.2).